Radiation Therapy for Cancer

No AccessNov 2015Radiation Therapy for CancerAuthors/Editors: David A. Jaffray, Mary K. GospodarowiczDavid A. JaffraySearch for more papers by this author, Mary K. GospodarowiczSearch for more papers by this authorhttps://doi.org/10.1596/978-1-4648-0349-9_ch14AboutView ChaptersFull TextPDF (0.3 MB) ToolsAdd to favoritesDownload CitationsTrack Citations ShareFacebookTwitterLinked In Abstract: Recognizes the essential role of radiation therapy (RT) in cancer treatment as a cost-effective modality despite the substantial outlay in facilities and equipment. RT can be used as a sole therapy, in conjunction with chemotherapy, following surgery, or in palliation. Three delivery methods – external beam radiation therapy, brachytherapy, and radioisotope therapy – are the most common, offered in specially designed facilities by specially trained teams of professionals. In cancer centers, RT departments collaborate with pathology, imagining, surgery, and palliative care groups. An access gap exists between high-income countries and low- and middle-income countries, with special attention needed for medical education, regulatory structure, and infrastructure in less developed countries. The International Atomic Energy Agency (IAEA) has brought attention to this inequity and organized the Programme of Action for Cancer Therapy to assess country readiness to develop RT facilities in light of resources available for cancer control. Planning has improved access in Brazil, Ireland, Canada, Kenya, and Poland. ReferencesAbdel-Wahab, M, J M Bourque, Y Pynda, J Izewska, and D Van der Merwe others. 2013. “Status of Radiotherapy Resources in Africa: An International Atomic Energy Agency Analysis.” The Lancet Oncology 14 (4): e168–75. doi:10.1016/s1470-2045(12)70532-6. CrossrefGoogle ScholarBanerjee, S, U Mahantshetty, and S Shrivastava. 2014. “Brachytherapy in India: A Long Road Ahead.” Journal of Contemporary Brachytherapy 6 (3): 331–35. CrossrefGoogle ScholarBarton, M B, M Frommer, and J Shafiq. 2006. “Role of Radiotherapy in Cancer Control in Low-Income and Middle-Income Countries.” The Lancet Oncology 7 (7): 584–95. doi:10.1016/s1470-2045(06)70759-8. CrossrefGoogle ScholarBarton, M B, S Jacob, J Shafiq, K Wong, and S R Thompson others. 2014. “Estimating the Demand for Radiotherapy from the Evidence: A Review of Changes from 2003 to 2012.” Radiotherapy & Oncology 112 (1): 140–44. doi:10.1016/j.radonc.2014.03.024. Epub May 12. CrossrefGoogle ScholarBenson, A B, J P Arnoletti 3rd, T Bekaii-Saab, E Chan, and Y J Chen others. 2012. “Anal Carcinoma, Version 2.2012: Featured Updates to the NCCN Guidelines.” Journal of the National Comprehensive Cancer Network 10 (4): 449–54. Google ScholarChalubinska-Fendler, J, W Fendler, J Luniewska-Bury, W Mlynarski, and M Spych others. 2014. “Tackling the Turmoil of Transformation: Radiation Oncology in Poland.” International Journal of Radiation Oncology, Biology, Physics 90 (3): 480–86. doi:10.1016/j.ijrobp.2014.05.031. CrossrefGoogle ScholarChen, R C, W U Shipley, J A Efstathiou, and A L Zietman. 2013. “Trimodality Bladder Preservation Therapy for Muscle-Invasive Bladder Cancer.” Journal of the National Comprehensive Cancer Network 11 (8): 952–60. Google ScholarDelaney, G, S Jacob, and M Barton. 2005a. “Estimating the Optimal External-Beam Radiotherapy Utilization Rate for Genitourinary Malignancies.” Cancer 103 (3): 462–73. doi:10.1002/cncr.20789. CrossrefGoogle ScholarDelaney, G, S Jacob, and M Barton. 2005b. “Estimation of an Optimal External Beam Radiotherapy Utilization Rate for Head and Neck Carcinoma.” Cancer 103 (11): 2216–27. doi:10.1002/cncr.21084. CrossrefGoogle ScholarEngstrom, P F, J P Arnoletti, A B Benson, J D Berlin 3rd, and J M Berry others. 2010. “NCCN Clinical Practice Guidelines in Oncology: Anal Carcinoma.” Journal of the National Comprehensive Cancer Network 8 (1): 106–20. Google ScholarFisher, B J, L C Daugherty, J P Einck, G Suneja, and M M Shah others. 2014. “Radiation Oncology in Africa: Improving Access to Cancer Care on the African Continent.” International Journal of Radiation Oncology, Biology, Physics 89 (3): 458–61. doi:10.1016/j.ijrobp.2013.12.032. CrossrefGoogle ScholarGlynne-Jones, R and A Renehan. 2012. “Current Treatment of Anal Squamous Cell Carcinoma.” Hematology/Oncology Clinics of North America 26 (6): 1315–50. doi:10.1016/j.hoc.2012.08.011. CrossrefGoogle ScholarGoksel, F, O Koc, N Ozgul, M Gultekin, and M Abacioglu others. 2011. “Radiation Oncology Facilities in Turkey: Current Status and Future Perspectives.” Asian Pacific Journal of Cancer Prevention 12 2157–62. Google ScholarGospodarowicz, M, J Trypuc, A D’Cruz, J Khader, S Omar, and F Knaul. 2015. “Cancer Services and the Comprehensive Cancer Center.” In Disease Control Priorities (third edition): Volume 3, Cancer, edited by Gelband, H, P Jha, R Sankaranarayanan, and S Horton. Washington, DC: World Bank. Google ScholarGoss, P E, B L Lee, T Badovinac-Crnjevic, K Strasser-Weippl, and Y Chavarri-Guerra others. 2013. “Planning Cancer Control in Latin America and the Caribbean.” The Lancet Oncology 14 (5): 391–436. doi:10.1016/s1470-2045(13)70048-2. CrossrefGoogle ScholarGregoire, V, J L Lefebvre, L Licitra, and E Felip Ehns-Esmo-Estro Guidelines Working Group. 2010. “Squamous Cell Carcinoma of the Head and Neck: EHNS-ESMO-ESTRO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-Up.” Annals of Oncology 21 (Suppl. 5): v184–86. doi:10.1093/annonc/mdq185. CrossrefGoogle ScholarGunderson, L L and J E Tepper. 2012. Clinical Radiation Oncology. 3rd ed. Philadelphia, PA: Saunders; London: Elsevier. Google ScholarHoppe, R T, R H Advani, W Z Ai, R F Ambinder, and P Aoun others. 2012. “Hodgkin Lymphoma, Version 2.2012: Featured Updates to the NCCN Guidelines.” Journal of the National Comprehensive Cancer Network 10 (5): 589–97. Google ScholarIAEA (International Atomic Energy Agency). 2008. Setting Up a Radiotherapy Programme: Clinical, Medical Physics, Radiation Protection and Safety Aspects. Vienna: IAEA. Google ScholarJaffray, D A 2012. “Image-Guided Radiotherapy: From Current Concept to Future Perspectives.” Nature Reviews Clinical Oncology 9 (12): 688–99. doi:10.1038/nrclinonc.2012.194. CrossrefGoogle ScholarJaffray, D A and M Gospodarowicz. 2014. “Bringing Global Access to Radiation Therapy: Time for a Change in Approach.” International Journal of Radiation Oncology, Biology, Physics 89 (3): 446–47. doi:10.1016/j.ijrobp.2014.05.019. CrossrefGoogle ScholarKnaul, F, S Horton, P Yerramilli, H Gelband, and R Atun. 2015. “Financing Cancer Care in Low-Resource Settings.” In Disease Control Priorities (third edition): Volume 3, Cancer, edited by Gelband, H, P Jha, R Sankaranarayanan, and S Horton. Washington, DC: World Bank. Google ScholarKoh, W J, B E Greer, N R Abu-Rustum, S M Apte, and S M Campos others. 2013. “Cervical Cancer.” Journal of the National Comprehensive Cancer Network 11 (3): 320–43. Google ScholarLambin, P, R G Van Stiphout, M H Starmans, E Rios-Velazquez, and G Nalbantov others. 2013. “Predicting Outcomes in Radiation Oncology: Multifactorial Decision Support Systems.” Nature Reviews Clinical Oncology 10 (1): 27–40. doi:10.1038/nrclinonc.2012.196. CrossrefGoogle ScholarMotzer, R J, N Agarwal, C Beard, G B Bolger, and B Boston others. 2009. “NCCN Clinical Practice Guidelines in Oncology: Testicular Cancer.” Journal of the National Comprehensive Cancer Network 7 (6): 672–93. Google ScholarPetrelli, F, A De Stefani, F Raspagliesi, D Lorusso, and S Barni. 2014. “Radiotherapy with Concurrent Cisplatin-Based Doublet or Weekly Cisplatin for Cervical Cancer: A Systematic Review and Meta-Analysis.” Gynecologic Oncology 134 (1): 166–71. doi:10.1016/j.ygyno.2014.04.049. CrossrefGoogle ScholarPfister, D G, K K Ang, D M Brizel, B A Burtness, and P M Busse others. 2013. “Head and Neck Cancers, Version 2. 2013. Featured Updates to the NCCN Guidelines.” Journal of the National Comprehensive Cancer Network 11 (8): 917–23. Google ScholarPurdie, T G, R E Dinniwell, A Fyles, and M B Sharpe. 2014. “Automation and Intensity Modulated Radiation Therapy for Individualized High-Quality Tangent Breast Treatment Plans.” International Journal of Radiation Oncology, Biology, Physics 90 (3): 688–95. doi:10.1016/j.ijrobp.2014.06.056. CrossrefGoogle ScholarRamos, M, S Benavente, and J Giralt. 2010. “Management of Squamous Cell Carcinoma of the Head and Neck: Updated European Treatment Recommendations.” Expert Review of Anticancer Therapy 10 (3): 339–44. doi:10.1586/era.10.6. CrossrefGoogle ScholarRodin, D, D Jaffray, R Atun, F M Knaul, and M Gospodarowicz others. 2014. “The Need to Expand Global Access to Radiotherapy.” The Lancet Oncology 15 (4): 378–80. doi:10.1016/s1470-2045(14)70121-4. CrossrefGoogle ScholarRosenblatt, E, J Izewska, Y Anacak, Y Pynda, and P Scalliet others. 2013. “Radiotherapy Capacity in European Countries: An Analysis of the Directory of Radiotherapy Centres (DIRAC) Database.” The Lancet Oncology 14 (2): e79–86. doi:10.1016/s1470-2045(12)70556-9. CrossrefGoogle ScholarSouchon, R, F Wenz, F Sedlmayer, W Budach, and J Dunst others. 2009. “DEGRO Practice Guidelines for Palliative Radiotherapy of Metastatic Breast Cancer: Bone Metastases and Metastatic Spinal Cord Compression (MSCC).” Strahlentherapie und Onkologie 185 (7): 417–24. doi:10.1007/s00066-009-2044-2. CrossrefGoogle ScholarTyldesley, S, G Delaney, F Foroudi, L Barbera, and M Kerba others. 2011. “Estimating the Need for Radiotherapy for Patients with Prostate, Breast, and Lung Cancers: Verification of Model Estimates of Need with Radiotherapy Utilization Data from British Columbia.” International Journal of Radiation Oncology, Biology, Physics 79 (5): 1507–15. doi:10.1016/j.ijrobp.2009.12.070. CrossrefGoogle ScholarZubizarreta, E H, E Fidarova, B Healy, and E Rosenblatt. 2015. “Need for Radiotherapy in Low and Middle Income Countries: The Silent Crisis Continues.” Clinical Oncology 27 (2): 107–14. doi:10.1016/j.clon.2014.10.006. CrossrefGoogle Scholar Previous chapterNext chapter FiguresreferencesRecommendeddetailsCited byRadiation-induced salivary gland damage/dysfunction in head and neck cancer: Nano-bioengineering strategies and artificial intelligence for prevention, therapy and reparationJournal of Radiology and Oncology, Vol.6, No.320 December 2022Adipose-Derived Stromal Cell-Based Therapies for Radiation-Induced FibrosisAdvances in Wound Care, Vol.139 December 2022Multi-view Unet for Automated GI Tract SegmentationPhase I trial of ATM inhibitor M3541 in combination with palliative radiotherapy in patients with solid tumorsInvestigational New Drugs, Vol.40, No.312 February 2022Relative Efficiency of Radiation Treatment Centers: An Application of Data Envelopment AnalysisHealthcare, Vol.10, No.62 June 2022Exceptional Survival Among Kentucky Stage IV Non‐small Cell Lung Cancer Patients: Appalachian Versus Non‐Appalachian PopulationsThe Journal of Rural Health, Vol.38, No.118 November 2020Integrating Data Envelopment Analysis into radiotherapy treatment planning for head and neck cancer patientsEuropean Journal of Operational Research, Vol.296, No.1Salivary Gland Radio-Protection, Regeneration and Repair: Innovative Strategies24 November 2021Thermal management of LINAC targetsRadiation-Induced Tissue Damage: Clinical Consequences and Current Treatment OptionsSeminars in Plastic Surgery, Vol.35, No.0310 September 2021Medical Visualization Using 3D Imaging and Volume Data: A Survey31 October 2020Role of Par-4 in Radiation Sensitivity of Cancer1 January 2022Radiotherapy and Its Impact on the Nervous System of Cancer SurvivorsCNS & Neurological Disorders - Drug Targets, Vol.19, No.5Activation of NRF2 by topical apocarotenoid treatment mitigates radiation-induced dermatitisRedox BiologyEstimating the Number of Patients Eligible for Carbon Ion Radiotherapy in the United StatesInternational Journal of Particle Therapy, Vol.7, No.25 November 2020Radiation Fibrosis Syndrome24 May 2020Prehabilitation for patient positioning: pelvic exercises assist in minimizing inter-fraction sacral slope variability during radiation therapyMedical Oncology, Vol.37, No.112 November 2019Hyperthermia can alter tumor physiology and improve chemo- and radio-therapy efficacyAdvanced Drug Delivery Reviews, Vol.163-164Quantitative assessment of the efficacy of two different treatment plan optimization algorithms in treating tumors in locations of high heterogeneityJournal of Radiation Oncology, Vol.8, No.23 July 2019HDAC2 Inhibitor Valproic Acid Increases Radiation Sensitivity of Drug-Resistant Melanoma CellsMedical Sciences, Vol.7, No.322 March 2019Intra-patient and inter-patient comparisons of DNA damage response biomarkers in Nasopharynx Cancer (NPC): analysis of NCC0901 randomised controlled trial of induction chemotherapy in locally advanced NPCBMC Cancer, Vol.18, No.112 November 2018Oxidative Stress in Hadrontherapy9 May 2018Integrative analysis for the role of long non-coding RNAs in radiation-induced mouse thymocytes responsesActa Biochimica et Biophysica Sinica, Vol.49, No.117 November 2016 View Published: November 2015ISBN: 978-1-4648-0349-9e-ISBN: 978-1-4648-0369-7 Copyright & Permissions Related TopicsHealth Nutrition and Population KeywordsPREVENTION AND DIAGNOSISCANCERHEALTH FINANCEACCESS TO HEALTH SERVICESCOST-EFFECTIVENESSLOW-INCOME COUNTRIESMIDDLE-INCOME COUNTRIESPALLIATIVE CAREHEALTH PROFESSIONALSMEDICAL EDUCATIONMEDICAL EQUIPMENT AND SUPPLIESQUALITY OF HEALTH CARECHEMOTHERAPYRADIATION THERAPYINTERNATIONAL ATOMIC ENERGY AGENCYIAEA PDF DownloadLoading ...